🏥 Marengo Asia Hospitals • Gurugram & Faridabad, Delhi NCR

Supportive & BMT Care in Gurgaon & Faridabad

Multi-disciplinary post-transplant care, rigorous infection control, and therapeutic monitoring designed to protect immunocompromised patients, prevent GvHD, and ensure sustained clinical recovery.

HEPA ICU

Positive Pressure Air Handling

24×7 Care

Transplant Intensivist Surveillance

PCR Panel

Preemptive CMV & Fungal Screening

Holistic

Nutrition, Psycho-Oncology & Rehab

Clinical Protection

Pillars of Comprehensive Supportive Care

A multi-layered defense protecting transplant patients through pre-conditioning, aplasia, and long-term engraftment.

Infection Control & Prophylaxis

Tailored broad-spectrum antibacterial, antifungal, and antiviral regimens combined with positive pressure HEPA filtration to safeguard patients during the critical post-conditioning neutropenic nadir.

Preemptive Antiviral & Fungal Prophylaxis

GvHD Management & Monitoring

Targeted immunosuppressive protocols (Calcineurin inhibitors, PTCy, and advanced JAK inhibitors) for early identification and control of acute and chronic Graft-versus-Host Disease.

Precision Immune Modulation

Clinical Nutrition & Rehabilitation

Sterile neutropenic dietary planning, total parenteral nutrition (TPN) when required, and personalized physiotherapy to maintain muscle mass and accelerate physical stamina.

Nutritional & Physical Recovery
Comprehensive Spectrum

Specialized Supportive Care Services Offered

Continuous clinical vigilance addressing acute medical complications and long-term survivorship.

Acute Post-Transplant Complications

  • Febrile Neutropenia Surveillance: Immediate bedside blood cultures and rapid empiric intravenous antibiotic escalation protocols.
  • CMV, EBV & BK Virus PCR Monitoring: Weekly molecular viral load tracking to preempt viral reactivation and hemorrhagic cystitis.
  • Invasive Fungal Infection Control: Dedicated prophylaxis against Aspergillosis, Mucormycosis, and Candida using therapeutic drug monitoring (TDM).
  • Sinusoidal Obstruction Syndrome (VOD/SOS): Early diagnostic ultrasound surveillance and prompt Defibrotide intervention pathways.

Long-Term Survivorship & Well-Being

  • Post-Transplant Revaccination Clinics: Structured re-immunization schedule initiated from 6 to 12 months post-engraftment.
  • Endocrine & Bone Health Surveillance: Monitoring thyroid function, gonadal health, and bone mineral density post-irradiation/steroids.
  • Psycho-Oncology Counseling: Dedicated emotional and psychological counseling for patients and family caregivers throughout isolation.
  • Palliative & Symptom Management: Dedicated pain management, antiemetic optimization, and mucositis relief protocols.
Recovery Timeline

The Supportive Care Pathway At Marengo Asia Hospitals

Guiding every patient through safe conditioning, protective isolation, and outpatient reintegration.

01

Pre-BMT Baseline

Infection serology, dental clearance, pulmonary function testing, and vascular access placement.

02

Aplasia Inpatient Care

Neutropenic nursing in positive pressure rooms, sterile diets, and daily lab monitoring.

03

Day 30–100 Outpatient

Weekly clinic visits, chimerism analysis, viral load PCR tracking, and immunosuppression titration.

04

Long-Term Survivorship

Annual organ screening, pediatric growth monitoring, revaccination, and quality-of-life support.

Positive Pressure HEPA Suites & Sterile Airflow Quality

At Marengo Asia Hospitals (Gurugram & Faridabad), our dedicated BMT units are engineered to ultra-clean standards. Every private room operates under continuous positive pressure with certified HEPA (High-Efficiency Particulate Air) filtration delivering more than 12 air changes per hour. This guarantees 99.97% filtration of airborne fungal spores and particulate matter down to 0.3 microns, drastically lowering secondary environmental infection risks.

Common Queries

Frequently Asked Questions on Supportive Care

What is Graft-versus-Host Disease (GvHD) and how is it managed?

GvHD is a condition where donor immune cells recognize the recipient's tissues as foreign, primarily affecting the skin, liver, and gastrointestinal tract. Our transplant hematologists employ proactive prophylaxis (such as Cyclosporine, Tacrolimus, Methotrexate, and Post-Transplant Cyclophosphamide) and second-line therapies (such as Ruxolitinib and photopheresis) to manage and resolve GvHD without compromising the curative anti-leukemia effect.

What financial support and patient welfare programs are available?

Supportive care medications (like advanced antifungals and growth factors) can impact treatment expenses. To support patients throughout recovery, Marengo Asia Hospitals provides:

Patient Funding Support Program: Dedicated coordination for insurance claim settlements, institutional assistance, and medical crowdfunding.
Compassionate Drug Access Programs: Facilitating subsidized or compassionate access to high-cost biologics and specialized therapies.
Rehabilitation Packages: Comprehensive outpatient follow-up packages bundling frequent lab monitoring and physician consultations at structured rates.

When can a patient resume normal work and social activities after a transplant?

Recovery depends on transplant type. Autologous BMT recipients typically begin resuming light everyday activities within 2 to 3 months. Allogeneic transplant recipients require longer immune rebuilding, generally resuming public activities and workplace reintegration between 6 and 12 months, once immunosuppressive medications have been safely tapered and initial revaccinations have begun.

Need Expert Post-Transplant or Supportive Care Guidance?

Connect with our Transplant Hematology & Critical Supportive Care Teams at Marengo Asia Hospitals, Gurugram & Faridabad for comprehensive patient evaluations and second opinions.